Quinoxaline derivatives useful as FGFR kinase modulators

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9902714
SERIAL NO

15128345

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to new quinoxaline derivative compounds of formula (I), to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASTEX THERAPEUTICS LTDBRITAIN CAMB CAMBRIDGE CAMBRIDGESHIRE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Broggini, Diego Fernando Domenico Zurich, CH 12 70
Cuyckens, Filip Albert Celine Aartselaar, BE 2 51
Hostyn, Steven Anna Hove, BE 5 52
Jones, Russell Mark Binningen, CH 5 51
Vermeulen, Wim Vosselaar, BE 8 58

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 27, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 27, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00